In vitro and in vivo selection of potentially probiotic lactobacilli from Nocellara del Belice table olives by Guantario, B et al.
ORIGINAL RESEARCH
published: 28 March 2018
doi: 10.3389/fmicb.2018.00595
Frontiers in Microbiology | www.frontiersin.org 1 March 2018 | Volume 9 | Article 595
Edited by:
Joaquin Bautista-Gallego,
Instituto de la Grasa (CSIC), Spain
Reviewed by:
Hikmate Abriouel,
Universidad de Jaén, Spain
Cinzia Lucia Randazzo,
Università degli Studi di Catania, Italy
*Correspondence:
Daniela Uccelletti
daniela.uccelletti@uniroma1.it
Chiara Devirgiliis
chiara.devirgiliis@crea.gov.it
†These authors have contributed
equally to this work.
Specialty section:
This article was submitted to
Food Microbiology,
a section of the journal
Frontiers in Microbiology
Received: 18 December 2017
Accepted: 15 March 2018
Published: 28 March 2018
Citation:
Guantario B, Zinno P, Schifano E,
Roselli M, Perozzi G, Palleschi C,
Uccelletti D and Devirgiliis C (2018)
In Vitro and in Vivo Selection of
Potentially Probiotic Lactobacilli From
Nocellara del Belice Table Olives.
Front. Microbiol. 9:595.
doi: 10.3389/fmicb.2018.00595
In Vitro and in Vivo Selection of
Potentially Probiotic Lactobacilli
From Nocellara del Belice Table
Olives
Barbara Guantario 1†, Paola Zinno 1†, Emily Schifano 2, Marianna Roselli 1, Giuditta Perozzi 1,
Claudio Palleschi 2, Daniela Uccelletti 2* and Chiara Devirgiliis 1*
1 Food & Nutrition Research Centre, Council for Agricultural Research and Economics, Rome, Italy, 2 Department of Biology
and Biotechnology “C. Darwin,” Sapienza University of Rome, Italy
Table olives are increasingly recognized as a vehicle as well as a source of probiotic
bacteria, especially those fermented with traditional procedures based on the activity
of indigenous microbial consortia, originating from local environments. In the present
study, we report characterization at the species level of 49 Lactic Acid Bacteria (LAB)
strains deriving from Nocellara del Belice table olives fermented with the Spanish
or Castelvetrano methods, recently isolated in our previous work. Ribosomal 16S
DNA analysis allowed identification of 4 Enterococcus gallinarum, 3 E. casseliflavus,
14 Leuconostoc mesenteroides, 19 Lactobacillus pentosus, 7 L. coryniformis, and 2
L. oligofermentans. The L. pentosus and L. coryniformis strains were subjected to
further screening to evaluate their probiotic potential, using a combination of in vitro
and in vivo approaches. The majority of them showed high survival rates under
in vitro simulated gastro-intestinal conditions, and positive antimicrobial activity against
Salmonella enterica serovar Typhimurium, Listeria monocytogenes and enterotoxigenic
Escherichia coli (ETEC) pathogens. Evaluation of antibiotic resistance to ampicillin,
tetracycline, chloramphenicol, or erythromycin was also performed for all selected
strains. Three L. coryniformis strains were selected as very good performers in the initial
in vitro testing screens, they were antibiotic susceptible, as well as capable of inhibiting
pathogen growth in vitro. Parallel screening employing the simplified model organism
Caenorhabditis elegans, fed the Lactobacillus strains as a food source, revealed that one
L. pentosus and one L. coryniformis strains significantly induced prolongevity effects and
protection from pathogen-mediated infection. Moreover, both strains displayed adhesion
to human intestinal epithelial Caco-2 cells and were able to outcompete foodborne
pathogens for cell adhesion. Overall, these results are suggestive of beneficial features
for novel LAB strains, which renders them promising candidates as starters for the
manufacturing of fermented table olives with probiotic added value.
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INTRODUCTION
The most recent definition of “probiotic” was formulated by
an expert consultation of international scientists working on
behalf of FAO/WHO (Food and Agriculture Organization/World
Health Organization), and refers to viable, non-pathogenic
microorganisms (bacteria and/or yeast) that when ingested in
adequate amounts, are able to reach and colonize the Gastro-
Intestinal (GI) tract and to confer health benefits to the
host (FAO/WHO, 2006). The main benefits associated with
probiotic intake include gut health and immune modulation
(Ritchie and Romanuk, 2012; Hill et al., 2014). In particular,
probiotic consumption can influence the microbial composition
and balance within the intestinal microbiota. Production of
antimicrobial substances such as organic acids, hydrogen
peroxide, antifungal peptides, and bacteriocins, contributes
to decrease harmful microorganisms and promotes growth
and stability of beneficial bacteria, such as lactobacilli and
bifidobacteria (Magnusson and Schnürer, 2001; Baker et al.,
2009; Abriouel et al., 2012; Amund, 2016; Hegarty et al., 2016).
Probiotic capacity greatly varies among strains belonging to
different genera and species. The most common bacterial strains
employed as probiotics are found within LAB (Lactic Acid
Bacteria) species belonging to the Bifidobacterium, Lactobacillus,
and Streptococcus genera (Saulnier et al., 2009). Members of
the Lactobacillus genus are especially relevant as foodborne
probiotics because they can be exploited also from the
technological viewpoint, as their metabolic properties lead to
production of a wide spectrum of molecules conferring specific
organoleptic quality to fermented products. Moreover, several
lactobacilli are considered Generally Recognized as Safe (GRAS)
and are largely used as starter and/or protective cultures in
fermented vegetables, sausages, fish and dairy products (Giraffa
et al., 2010; Garrigues et al., 2013; Montoro et al., 2016).
The growing demand for plant-based foods is presently
driving selection of bacteria which are able to grow on
fermentable vegetable sources (Granato et al., 2010). Vegetable
fermented foods such as table olives, pickles, sauerkraut, and
kimchi, are slowly overtaking the role of fermented products
of animal origin (dairies and sausages) as leading source of
live bacteria in human diets, and they are also increasingly
considered as novel reservoirs of yet uncharacterized probiotic
strains (Ranadheera et al., 2010). Table olives could therefore
represent a natural source for the isolation of novel probiotic
bacterial strains. This is especially true for those olives fermented
with traditional procedures relying on the activity of indigenous
microbial consortia of environmental origin. The microbiota
of processed olives and brines includes, among others, several
LAB species such as L. plantarum, L. pentosus, L. paracasei,
L. rhamnosus, Leuconostoc mesenteroides (Arroyo-López et al.,
2008; Hurtado et al., 2012; Zinno et al., 2017).
Fermented vegetable matrices are presently recognized not
only as a source, but also as a vehicle of probiotic bacteria. Recent
studies demonstrated that LAB species isolated from different
table olive cultivars exhibit probiotic features, such as resistance
to acid and bile salts, antimicrobial activity and interaction with
intestinal epithelial cells. This suggests their potential application
as novel probiotic candidates for in vivo studies in animals
and humans (Bevilacqua et al., 2010; Abriouel et al., 2012;
Argyri et al., 2013; Botta et al., 2014; Montoro et al., 2016).
However, simplified in vitro/in vivo models represent useful
and less expensive screening tools to identify probiotic strains
from a large number of microbial candidates. Human intestinal
epithelial Caco-2 cells are a well characterized enterocyte-like
cell line, capable of expressing the morphological and functional
differentiation features which are typical of mature enterocytes,
including cell polarity and a functional brush border (Sambuy
et al., 2005). The Caco-2 cell line has been extensively used
as a reliable in vitro system to study the adhesion capacity of
lactobacilli as well as their probiotic effects, such as protection
against intestinal injury induced by pathogens (Liévin-Le Moal
et al., 2002; Resta-Lenert and Barrett, 2003; Roselli et al., 2006;
Montoro et al., 2016).
The nematode Caenorhabditis elegans is becoming an
increasingly valuable in vivo model to study host-probiotic
interactions. Its success lies in the transparency of the body, in
the small size and in the absence of ethical issues. Moreover, it is
inexpensive to maintain and suitable for screening studies (Clark
andHodgkin, 2014).C. elegans is a powerful tool to test the effects
of ingested bacteria on host physiology and it can also be useful
in providing mechanistic insights on the beneficial effects of
probiotics. A growing number of studies employing theC. elegans
model system demonstrated that ingestion of lactobacilli and
bifidobacteria can prolong the lifespan of nematodes and modify
host defense (Kim andMylonakis, 2012; Komura et al., 2013; Park
et al., 2015). The L. gasseri strain SBT2055, which was reported
to exert beneficial effects in mice and humans, showed a positive
impact on longevity and/or aging in this nematode (Nakagawa
et al., 2016). The health-promoting L. delbrueckii subspecies
bulgaricus was also found to increase the lifespan of nematodes
(Zanni et al., 2017), further highlighting the power of this in vivo
model.
The aim of the present study was the identification
and characterization of novel potentially probiotic strains of
L. pentosus and L. coryniformis, deriving from a LAB collection
of isolates from Nocellara del Belice table olives (Zinno et al.,
2017). We used a combination of in vitro and in vivo approaches,
including Caco-2 cell cultures and the C. elegans nematode
model, to select specific strains displaying beneficial host-
microbe interactions. The autochtonous nature of the food
fermenting microbiota of origin, as well as the GRAS status of
LAB species, allows to employ these strains as starter cultures
in food fermentations, with the added value of providing health
promoting traits.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The LAB strains described in this work, as well as
reference strains L. plantarum ATCC R© 14917TM, L. pentosus
ATCC R© 8041TM and L. rhamnosus GG ATCC R© 53103TM
(LGG), were grown in De Man Rogosa Sharpe (MRS) medium
for 24–48 h at 30 or 37◦C under anaerobic conditions. The
enterotoxigenic Escherichia coli strain K88 (ETEC, O149:K88ac,
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provided by The Lombardy and Emilia Romagna Experimental
Zootechnic Institute, Reggio Emilia, Italy) and E. coli strain
OP50 were grown in Luria-Bertani (LB) broth at 37◦C overnight.
Salmonella enterica serovar Typhimurium LT2 and Listeria
monocytogenes OH were routinely grown in Tryptone Soya
Broth (TSB) at 37 and 30◦C, respectively. All media and
supplements were provided by Oxoid (Milan, Italy).
Species Identification
For taxonomical identification, 16S rDNA gene fragments
were amplified from LAB isolates using the P0-P6 primer
pair (P0: 5′-GAGAGTTTGATCCTGGCT-3′; P6: 5′-
CTACGGCTACCTTGTTAC-3′; Di Cello and Fani, 1996).
Two µl of DNA extracted by microlysis were used for PCR
amplification with the following program: 95◦C for 10min, 30
cycles at: 94◦C for 1min, 55◦C for 90 s, 72◦C for 150 s; one step
at 55◦C for 10min followed by a final step at 72◦C for 10min.
Amplified PCR fragments were analyzed by gel electrophoresis in
0.8% agarose in 1X TAE and then purified with NucleoSpin Gel
and PCR clean-up purification kit (Macherey-Nagel, Germany).
Sequencing of purified 16S rDNA fragments was performed
at Bio-Fab Research (Italy) laboratories. For taxonomical
identification, DNA sequences were compared with those
reported in the BLAST NCBI (National Center for Biotechnology
Information, Bethesda, USA) database. Nucleotide sequences of
the amplified 16S rDNA from each LAB isolate were submitted
to GenBank, and the corresponding accession numbers are
reported in Table 1.
Multiplex PCR Assay
L. plantarum/L. pentosus strains were subjected to a multiplex
PCR assay using the recA gene-based primers paraF (5′-GTC
ACA GGC ATT ACG AAA AC-3′), pentF (5′-CAG TGG CGC
GGT TGA TAT C-3′), planF (5′-CCG TTT ATG CGG AAC
ACC TA-3′), and pREV (5′-TCG GGA TTA CCA AAC ATC
AC-3′; Torriani et al., 2001). The PCR mixture included 1.5mM
MgCl2, the primers paraF, pentF, and pREV (0.25µM each),
0.12µMprimer planF, 0.2mM dNTPs, 3U TaqDNA Polymerase
(Invitrogen, Carlsbad, USA). Two µl of DNA extracted by
microlysis were used for the reaction. PCR programs consisted
of an initial denaturation step at 94◦C for 3min, followed by 30
cycles of amplification (denaturation at 94◦C for 30 s, annealing
at 56◦C for 10 s, and elongation at 72◦C for 30 s), and a final
extension step at 72◦C for 5min. The PCR products were
visualized on a 2% agarose gel in 1X TAE buffer and digitally
captured by using ImageQuant LAS 4000 (GE Healthcare Life
Sciences, Little Chalfont, UK).
Rep-PCR Fingerprinting
Two µl of DNA extracted by microlysis from selected
L. coryniformis and L. pentosus strains (Microzone, Haywards
Heath, UK) were used for PCR amplification with primer
GTG5 (5′-GTGGTGGTGGTGGTG-3′), as previously
described (Zinno et al., 2017), or with the ERIC primer
(ERIC1R: 5′-ATGTAAGCTCCTGGGGATTCAC-3′; ERIC2: 5′-
AAGTAAGTGACTGGGGTGAGCG-3′; de La Puente-Redondo
et al., 2000).
For ERIC Rep-PCR, DNA amplification was carried out
in 25 µl PCR mixture containing 1X PCR buffer, 1.5mM
MgCl2, 0.2mM dNTPs, 3U of TaqDNA Polymerase (Invitrogen,
Carlsbad, USA) and 0.6µM primers. Each cycle consisted of
an initial denaturation step at 95◦C for 3min followed by 30
cycles of amplification (94◦C for 1min, 40◦C for 1min, 72◦C for
1min), and a final extension step at 72◦C for 8min. Amplified
products were analyzed by gel electrophoresis (80V for 4 h)
in 1.8% agarose in 1X TAE. The gels were visualized under
UV and digitally captured by using ImageQuant LAS 4000 (GE
Healthcare Life Sciences, Little Chalfont, UK).
Acid and Bile Salt Tolerance Assay
Tolerance to gastrointestinal conditions of selected
L. coryniformis and L. pentosus strains was evaluated according
to (Vizoso Pinto et al., 2006). Three ml of overnight bacterial
suspensions were centrifuged at 5,000 × g for 15min at 4◦C and
the corresponding pellet was diluted 1:1 in a sterile electrolyte
solution simulating salivary juice (Simulated Salivary Juice,
SSJ), composed of 6.2 g/l NaCl, 2.2 g/l KCl, 0.22 g/l CaCl2, 1.2
g/l NaHCO3 pH 6.9 in which lysozyme was added to a final
concentration of 100 mg/l. The mixed suspension was incubated
for 5min at 37◦C. Subsequently, the sample was diluted 3:5 with
Simulated Gastric Juice (SGJ) containing 6.2 g/l NaCl, 2.2 g/l
KCl, 0.22 g/l CaCl2, 1.2 g/l NaHCO3 pH 2.5 and 3 g/l pepsin,
and incubated for 1 h at 37◦C. After incubation, 1ml aliquot
of the sample was serially diluted and plated, in triplicate, onto
MRS agar. The remaining sample was diluted 1:4 in Simulated
Pancreatic Juice (SPJ) consisting of 6.4 g/l NaHCO3, 0.239 g/l
KCl, 1.28 g/l NaCl, 0.5% bile extract, 0.1% pancreatin at pH 7.2,
and incubated for 3 h at 37◦C. At 2 and 3 h incubation times,
1ml aliquots were withdrawn, serially diluted and plated on
MRS agar. Aliquots of overnight inocula were also tested to
determine the CFU/ml at the initial time point (t0) for each
strain. In parallel, control samples were treated with Phosphate
Buffered Saline (PBS) and subjected to the same procedure.
Survival capacity was calculated as the percentage of 1– [(log
CFU/mlt0-log CFU/mlSPJ3h)/log CFU/mlt0], where CFU/mlSPJ3h
represented the total viable counts (CFU/ml) for each strain
at the final time point of incubation in SPJ, and CFU/mlt0
represented the total viable counts at the initial time point. All
enzymes and salts used in the assay were provided by Sigma
Aldrich (Milan, Italy).
Antibiotic Susceptibility Tests
Antibiotic susceptibility was performed for a selected panel
of antibiotics, namely ampicillin, tetracycline, chloramphenicol,
and erythromycin, chosen as representatives of the most
commonly used pharmacological classes of antimicrobials.
For L. pentosus, each antibiotic was used at the breakpoint
concentration defined by the FEEDAP Panel (EFSA, 2012).
For L. coryniformis, which was not listed in the EFSA
guidance document, we referred to the antibiotic concentrations
reported by (Lara-Villoslada et al., 2007). Two µl of overnight
bacterial cultures (OD600 = 1.3) were spotted onto MRS agar
plates containing ampicillin, tetracycline, chloramphenicol or
erythromycin, which were used at the following breakpoint
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TABLE 1 | List of LAB isolates deriving from Nocellara del Belice table olives fermented with Sivigliano or Castelvetrano methods and related species identified by 16S
rDNA sequencing.
Strain ID Bacterial species % Identity with reference
species in BLAST database
Source of isolation GenBank accession number
C303.8 Enterococcus gallinarum 99 Castelvetrano MG585222
C301.1 Enterococcus gallinarum 99 Castelvetrano MG585223
C302.1 Enterococcus casseliflavus 99 Castelvetrano MG585224
C302.4 Enterococcus casseliflavus 99 Castelvetrano MG585225
C303.6 Enterococcus casseliflavus 99 Castelvetrano MG585226
C304.2 Leuconostoc mesenteroides 99 Castelvetrano MG585227
I307.27 Leuconostoc mesenteroides 99 Sivigliano MG953414
G307.7 Leuconostoc mesenteroides 99 Sivigliano MG585228
G3010.28 Leuconostoc mesenteroides 99 Sivigliano MG585229
G3010.29 Leuconostoc mesenteroides 99 Sivigliano MG585230
H306.1 Leuconostoc mesenteroides 99 Sivigliano MG585231
I307.20 Leuconostoc mesenteroides 99 Sivigliano MG585232
I307.22 Leuconostoc mesenteroides 99 Sivigliano MG585233
I307.29 Leuconostoc mesenteroides 99 Sivigliano MG585234
I306.9 Leuconostoc mesenteroides 99 Sivigliano MG585235
I3010.34 Leuconostoc mesenteroides 99 Sivigliano MG585236
L309.4 Leuconostoc mesenteroides 98 Sivigliano MG585237
C305.2 Leuconostoc mesenteroides 99 Castelvetrano MG585238
C305.16 Leuconostoc mesenteroides 99 Castelvetrano MG585257
C305.5 Lactobacillus pentosus 99 Castelvetrano MG585239
D301.4 Lactobacillus pentosus 99 Castelvetrano MG585240
D302.23 Lactobacillus pentosus 98 Castelvetrano MG585241
D302.29 Lactobacillus pentosus 99 Castelvetrano MG585242
G306.1 Lactobacillus pentosus 99 Sivigliano MG585243
G306.2 Lactobacillus pentosus 99 Sivigliano MG585244
G308.65 Lactobacillus pentosus 99 Sivigliano MG953413
H3010.5 Lactobacillus pentosus 99 Sivigliano MG585245
I306.2 Lactobacillus pentosus 99 Sivigliano MG585246
H308.2 Lactobacillus pentosus 99 Sivigliano MG585247
I308.32 Lactobacillus pentosus 100 Sivigliano MG585248
D303.36 Lactobacillus pentosus 99 Castelvetrano MG585249
H3010.1 Lactobacillus pentosus 99 Sivigliano MG585250
I306.12 Lactobacillus coryniformis 99 Sivigliano MG585251
H307.1 Lactobacillus coryniformis 99 Sivigliano MG585252
C305.1 Lactobacillus coryniformis 99 Castelvetrano MG585253
H307.6 Lactobacillus coryniformis 99 Sivigliano MG585254
C303.1 Lactobacillus oligofermentans 99 Castelvetrano MG585255
G3010.31 Lactobacillus oligofermentans 99 Sivigliano MG585256
C371.10 Enterococcus gallinarum 97 Castelvetrano MG585258
C373.1 Enterococcus gallinarum 98 Castelvetrano MG585259
D371.5 Lactobacillus pentosus 99 Castelvetrano MG585260
D372.20 Lactobacillus pentosus 99 Castelvetrano MG585261
D373.37 Lactobacillus pentosus 99 Castelvetrano MG585262
I379.8 Lactobacillus pentosus 99 Sivigliano MG585263
G377.8 Lactobacillus pentosus 99 Sivigliano MG585264
G378.30 Lactobacillus pentosus 99 Sivigliano MG585265
H376.2 Lactobacillus coryniformis 98 Sivigliano MG585266
H376.5 Lactobacillus coryniformis 99 Sivigliano MG585267
H377.3 Lactobacillus coryniformis 99 Sivigliano MG585268
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concentrations: 2 mg/l, 32 mg/l, 8 mg/l, 1 mg/l, respectively, for
L. pentosus, and 10 mg/l, 30 mg/l, 30 mg/l, 15 mg/l, respectively,
for L. coryniformis. Plates were incubated for 24 h at 37◦C
in anaerobic conditions. Strains able to grow were considered
resistant (R). The Minimum Inhibitory Concentration (MIC)
for ampicillin and erythromycin of selected resistant strains
was determined by broth microdilution assay, as described in
(Devirgiliis et al., 2008). The antibiotic concentrations tested
ranged from 1 to 20 mg/l and from 0.5 to 10 mg/l for ampicillin
and erythromycin, respectively. Antibiotics were provided by
Sigma Aldrich (Milan, Italy).
Antimicrobial Activity
To evaluate the antagonistic activity of L. coryniformis and
L. pentosus strains against pathogens the agar double-layer
diffusion method was performed (Damaceno et al., 2017). The
indicator strains used were: S. enterica serovar Typhimurium
LT2, L. monocytogenes OH and ETEC K88. Two µl/each of
L. coryniformis and L. pentosus overnight cultures (OD600 = 1.3)
were spotted onto MRS agar and incubated at 37◦C for 24 h
in anaerobic conditions. After incubation, cells were killed by
chloroform exposure for 30min. Plates were then overlaid with
7ml TSA soft agar, which had been previously inoculated with
1% (v/v) of each pathogen indicator strain, and incubated at
the corresponding optimal growth temperature for 24 h. The
antagonist activity was recorded as the diameter (mm) of growth
inhibition halo around each spot.
Caco-2 Cell Culture and Growth Conditions
The human intestinal Caco-2/TC7 cell line was provided by
Monique Rousset (Institute National de la Santé et de la
Recherche Médicale, INSERM, France). These cells derive from
parental Caco-2 cells, exhibit a more homogeneous expression of
differentiation traits, and have been reported to express higher
metabolic and transport activities than the original cell line,
more closely resembling small intestinal enterocytes (Caro et al.,
1995). The Caco-2/TC7 cells were routinely maintained at 37◦C
in an atmosphere of 10% CO2/95% air at 90% relative humidity
and grown on plastic tissue culture flasks (Becton Dickinson,
Milan, Italy) in Dulbecco’s modifiedMinimumEssentialMedium
(complete DMEM: 3.7 g/L NaHCO3, 4mM glutamine, 10% heat
inactivated fetal calf serum, 1% nonessential amino acids, 105 U/l
penicillin and 100 mg/l streptomycin). All cell culture reagents
were from Euroclone (Milan, Italy).
Competition Assay for Pathogen Adhesion
to Caco-2 Cells
Caco-2 cells were seeded in 12-well plates (Becton Dickinson)
and, after confluency, were left for 14-17 days to allow
differentiation (Sambuy et al., 2005). Medium was changed three
times a week. Complete DMEMwas replaced with antibiotic- and
serum-free DMEM 16 h before the assay. To test the capacity of
the selected L. pentosus and L. coryniformis strains to compete
with pathogens for adhesion to Caco-2 cells, S. enterica serovar
Typhimurium LT2 and L. monocytogenes OH pathogens were
used as test strains. Preliminary experiments were performed
to set up the optimal growth conditions for pathogens as well
as for lactobacilli, to ensure that each strain could be used at
the exponential growth phase. The viability of pathogens and
lactobacilli in DMEM was also previously verified. On the day
of the assay, overnight bacterial cultures were diluted 1:10 in LB
(pathogens) or MRS media (lactobacilli) and grown for 4, 5, or
6 h to the exponential growth phase, according to the respective
optimal conditions previously identified for each strain. After
monitoring the OD600, appropriate amounts of bacterial cells
were harvested by centrifugation at 5,000 × g for 10min,
resuspended in antibiotic- and serum-free DMEM and added
to cell monolayers at a concentration of 1 × 107 CFU/well
(pathogens) or 1 × 108 CFU/well (lactobacilli). Cells were
incubated at 37◦C for 1.5 h with either one of the two pathogens,
alone or in combination with one of the two Lactobacillus
strains. After incubation at 37◦C for 1.5 h, non-adhering
bacteria were removed by 5 washes with Hanks’ Balanced Salt
solution (HBSS: 137mM NaCl, 5.36mM KCl, 1.67mM CaCl2,
1mM MgCl2, 1.03mM MgSO4, 0.44mM KH2PO4, 0.34mM
Na2HPO4, 5.6mM glucose) and cell monolayers were lysed with
1% Triton-X-100, according to (Roselli et al., 2006). Adhering,
viable pathogen cells were quantified by plating appropriate serial
dilutions of Caco-2 lysates on Violet Red Bile Glucose Agar
(VRBGA, for Salmonella) or Listeria Selective Agar Base (Oxford,
for Listeria). These two media were selective for pathogens,
preventing the growth of lactobacilli.
C. elegans Strain and Growth Conditions
The wild-type C. elegans strain, Bristol N2, was grown at 16◦C
on Nematode Growth Medium NGM plates covered by a layer of
E. coli OP50, LGG, L. coryniformis, or L. pentosus strains, which
were prepared as described in (Zanni et al., 2015).
C. elegans Lifespan Assay
Synchronized N2 adults were placed to lay embryos for 2 h on
NGM plates, lawned with different bacteria, and then sacrificed.
All lifespan assays started when the progeny became fertile (t0).
Animals were transferred to new plates seeded with fresh lawns
and monitored daily. They were scored as dead when they no
longer responded to gentle touch with a platinum wire. At least
60 nematodes per condition were used in each experiment.
Estimation of Bacterial Titer Within the
Nematode Gut
For each experiment, 10 days old animals were washed and lysed
according to (Uccelletti et al., 2010). Worm lysates were then
plated onto MRS-agar plates. The number of CFU was counted
after 48 h of incubation at 37◦C, anaerobically.
Nematode Brood Size Measurements
Progeny production was evaluated according to (Zanni et al.,
2015) with some modifications. Briefly, synchronized worms
obtained as above were grown on NGM plates seeded with
bacteria and then allowed to lay embryos at 16◦C. Next, animals
were transferred onto a fresh bacteria plate every day, and
the number of progeny was counted with a Zeiss Axiovert
25 microscope. The procedure was repeated until the mother
worms stopped laying eggs. Each day the progeny production
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was recorded and was compared with the OP50- or LGG-fed
nematodes.
Pharyngeal Pumping Assay
Pharyngeal pumping was analyzed as described in (Uccelletti
et al., 2008) under Zeiss Axiovert 25 microscope by counting the
number of grinder contractions of 10 animals for each treatment,
during a period of 30 s. The analysis was performed in 13-days-
adult worms, grown on different bacteria starting from embryo
stage.
Body Bending Evaluation
The locomotion behavior of nematodes, fed with different
bacteria from embryos hatching, was analyzed by body bending
counting after 30 s. After several washes in M9 buffer to remove
bacteria, nematodes were placed in 10 µl of M9 buffer allowing
them to swim freely. About 10 worms for each experimental
condition were monitored.
Lipofuscin Analysis
The autofluorescence of intestinal lipofuscin was measured as
an index of senescence at day 13 of adulthood. Randomly
selected worms from the plate lawned with bacteria were washed
three times with M9 buffer. Worms were then placed onto
a 3% agar pad containing 20mM sodium azide. Lipofuscin
autofluorescence was detected by fluorescence microscopy (Zeiss
Axiovert 25).
C. elegans Killing Assay
For killing assay 35 mm-NGM plates were spread with 60 µl
of L. pentosus D303.36 or L. coryniformis H307.6 mixed with
S. enterica serovar thyphimurium LT2 or L. monocytogenes OH,
in 1:1 ratio; the strains were grown as indicated above. C. elegans
synchronous L4 larvae were transferred onto the bacterial lawn
and incubated at 25◦C. Worms were monitored every day.
Nematodes fed with pathogen alone were taken as control. A
worm was considered dead when it failed to respond to touch.
Statistical Analysis
All experiments were performed at least in triplicate. Data
are presented as mean ± SD. Prior to the analysis, normal
distribution and homogeneity of variance of all variables were
assumed with Shapiro-Wilk and Levene’s tests, respectively.
For in vivo experiments in C. elegans the statistical significance
was determined by Student’s t-test or one-way ANOVA
analysis coupled with a Bonferroni post test (GraphPad
Prism 5.0 software, GraphPad Software Inc., La Jolla, CA,
USA). For in vitro experiments, statistical significance
was evaluated by one-way ANOVA, followed by post-hoc
Tukey honestly significant difference (HSD) test. Statistical
univariate analysis was performed with the “Statistica”
software package (version 5.0; Stat Soft Inc., Tulsa, OK).
Differences with p-values < 0.05 were considered significant
and were indicated as follows: ∗p < 0.05, ∗∗p < 0.01, and
∗∗∗p < 0.001.
RESULTS
Species Identification of LAB Isolates
A total of 49 Lactic Acid Bacteria strains deriving from
Nocellara del Belice table olives fermented with Spanish or
Castelvetrano methods, recently collected in our previous work
(Zinno et al., 2017), were characterized at the species level.
Ribosomal 16S DNA sequencing allowed the identification of 4
Enterococcus gallinarum, 3 E. casseliflavus, 14 L. mesenteroides,
7 L. coryniformis and 2 L. oligofermentans (Table 1). For 19
isolates, however, similarity searches using sequenced ribosomal
DNA fragments retrieved ambiguous species assignments, as the
genomic sequences matched both L. pentosus and L. plantarum
with similar scores. These isolates were therefore subjected to
a multiplex PCR assay, using recA gene-based primers, which
are able to discriminate L. plantarum, L. paraplantarum, and
L. pentosus species (Torriani et al., 2001). The PCR results
clarified that all 19 strains belonged to the L. pentosus species
(Figure S1). L. pentosus and L. coryniformis isolates were
chosen as potential probiotic candidates for further screening,
as these two species are widely employed as starter and/or
protective cultures in table olive manufacturing. To assess the
presence of unique strains, these isolates were subjected to
strain typing using a combination of GTG5 rep-PCR (Figure 1)
and of Enterobacterial Repetitive Intergenic Consensus sequence
PCR (ERIC-PCR, data not shown). The results shown in
Figure 1 revealed the presence of distinct fingerprinting profiles
characterizing each strain within both species, indicating that
each of the 19 L. pentosus and 7 L. coryniformis isolates
represented a unique strain. Therefore, they were all subjected
in parallel to the subsequent assays aimed at characterizing
probiotic capacity.
In Vitro Tolerance to Simulated
Gastro-Intestinal Conditions
Tolerance to gastrointestinal conditions was assayed using a
series of sequential treatments that simulate bacterial transit
along the mammalian GI tract. As shown in Table 2, each
treatment differentially affected survival of the tested strains.
In particular, 1 h incubation in SGJ, characterized by acidic
pH (2.5), exerted a mild but significant reduction of bacterial
counts for all the L. coryniformis and L. pentosus strains. Percent
survival was close to 90% in all cases, with the exception of
L. coryniformis isolate I306.12 which was almost unaffected by
this treatment (98% survival), while two other L. coryniformis
strains (C305.1 andH376.2) were unable to survive this condition
(Table 2). Subsequent treatment of the surviving strains with SPJ
containing bile salts and pancreatin, displayed a more severe
impact on overall bacterial survival, as revealed by the inability
of 5 L. pentosus strains to tolerate pancreatic conditions after
2 h of incubation (Table 2). Both 2 and 3 h treatments in SPJ
are usually employed to mimick transit time in the GI tract. In
our case however, 3 h incubation in SPJ did not affect overall
bacterial survival any further than the 2 h incubation timepoint,
with the exception of the L. pentosus strain G378.30 which did
not survive, and of 5 L. pentosus strains that showed a decrease
of about 1.5 log in CFU/ml. In order to compare the results
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FIGURE 1 | Strain typing of the selected L. pentosus and L. coryniformis isolates by rep-PCR. Agarose gel electrophoresis of GTG5 rep-PCR fingerprinting profiles of
L. coryniformis and L. pentosus strains. M: 1 kb DNA ladder (Microzone, UK).
obtained, survival capacity was calculated for each strain as well
as for the reference probiotic strain LGG (see Materials and
Methods). Overall, the capacity of the tested strains to tolerate
gastrointestinal conditions ranged between 50 and 80%. Notably,
7 L. pentosus and 4 L. coryniformis strains showed survival
capacities similar or higher than those of the reference probiotic
strain LGG, namely about 70% at the end of both treatments
(Table 2).
Antibiotic Resistance
The L. coryniformis and L. pentosus strains were analyzed
for resistance to ampicillin, tetracycline, chloramphenicol, and
erythromycin, as representatives of different pharmacological
classes of antimicrobials widely employed in human and
veterinary medicine. The selected antibiotics were used at the
breakpoint concentrations proposed by the European Food
Safety Agency (EFSA) for L. pentosus (EFSA, 2012), while for
L. coryniformis they were chosen according to (Lara-Villoslada
et al., 2007).Table 3 shows the antibiotic resistance panel for each
tested bacterial strain. Overall, the majority of the tested strains
displayed susceptibility to the selected antibiotics. However,
all L. pentosus strains displayed resistance to ampicillin, with
the exception of isolate C305.5. As for the other antibiotics,
all 19 L. pentosus strains were sensitive to tetracycline and
chloramphenicol, while 3 strains, namely D303.36, H3010.1,
and I379.8, displayed phenotypic resistance to erythromycin.
All L. coryniformis strains resulted susceptible to all tested
antibiotics (Table 3). The ampicillin and erythromycin resistant
L. pentosus strains were further investigated by quantifying
their MIC values for the two antibiotics. MIC values above
the breakpoints, corresponding to 2 mg/l for ampicillin and 1
mg/l for erythromycin, were considered indicative of phenotypic
antibiotic resistance. The results show that ampicillin MIC values
ranged between 2 and 20 mg/l, with variable distribution within
the 18 analyzed strains. Three of them, namely L. pentosus
D303.36, H3010.1, and I379.8, which were resistant to both
antibiotics, also displayed erythromycin MIC values of 1.125 or
2.5 mg/l (Table 3).
Antimicrobial Activity Against Pathogens
The great majority of the L. pentosus and L. coryniformis
strains displayed antagonistic activity in the agar double-layer
diffusion test against all three pathogens chosen as indicator
strains (S. enterica serovar Typhimurium LT2, L. monocytogenes
OH, and ETEC K88). The strength of such inhibition was
variable among the different lactobacilli, as shown by broad
variability of the inhibition halo diameters on all 3 pathogen
test strains (Table S1). The only exception was represented by
L. pentosus strain C305.5, which was unable to inhibit growth
of S. enterica serovar Typhimurium LT2 (Table 4). In particular,
the majority of the 19 L. pentosus strains produced inhibition
halo diameters above median value when tested against all
three pathogens. The L. coryniformis strains, on the other hand,
showed overall inhibition halo diameters between 1mm and the
corresponding median value against all three pathogens, with
the exception of two strains, namely H307.1 and H377.3, both
displaying inhibition halo diameters above the median against
Salmonella and ETEC (Table 4). Notably, both of these latter
strains had shown survival capacities comparable to that of
the well characterized probiotic strain LGG following simulated
gastro-intestinal condition, and were both susceptible to all tested
antibiotics.
In Vivo Screening in C. elegans
In vivo screening of the L. pentosus and L. coryniformis strains for
health-promoting traits was performed in the C. elegans model
system, which was shown to display beneficial effects in response
to administration of probiotic bacteria (Nakagawa et al., 2016).
Lifespan analysis was initially used as a pre-screening assay to
select those bacterial strains able to prolong worm longevity.
To this aim, the lifespan of animals separately fed each of the
isolated Lactobacillus strains starting from embryo hatching, was
compared with that of control worms grown on LGG as the
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TABLE 2 | Survival of L. pentosus and L. coryniformis strains under in vitro simulated gastro-intestinal conditions.
Bacterial species Strain ID t0 SGJ SPJ 2h SPJ 3h Survival capacity (%)
L. pentosus C305.5 8.20 ± 0.02a 7.53 ± 0.03b 6.18 ± 0.02c 6.14 ± 0.03c 74.92
D301.4 9.12 ± 0.08a 7.75 ± 0.15b 0 0 0
D302.23 8.93 ± 0.03a 8.40 ± 0.07b 0 0 0
D302.29 9.23 ± 0.003a 8.70 ± 0.05b 0 0 0
G306.1 8.31 ± 0.18a 7.77 ± 0.05b 5.97 ± 0.07c 5.94 ± 0.07c 71.44
G306.2 8.91 ± 0.12a 8.43 ± 0.02b 6.99 ± 0.02c 6.91 ± 0.05c 77.60
G308.65 9.09 ± 0.06a 8.30 ± 0.02b 0 0 0
H3010.5 9.49 ± 0.09a 8.48 ± 0.05b 6.20 ± 0.12c 4.72 ± 0.15d 49.76
I306.2 8.61 ± 0.13a 8.07 ± 0.09b 6.69 ± 0.03c 6.50 ± 0.10c 75.47
H308.2 8.63 ± 0.24a 8.10 ± 0.05b 6.66 ± 0.04c 5.99 ± 0.10d 69.43
I308.32 9.19 ± 0.01a 8.06 ± 0.02b 0 0 0
G377.8 9.38 ± 0.32a 8.23 ± 0.01b 6.77 ± 0.02c 6.44 ± 0.07c 68.64
G378.30 9.17 ± 0.19a 8.08 ± 0.07b 5.52 ± 0.30c 0 0
D303.36 9.05 ± 0.14a 8.54 ± 0.03b 5.21 ± 0.07c 4.68 ± 0.04d 51.65
H3010.1 8.92 ± 0.21a 6.81 ± 0.35b 5.01 ± 0.06c 4.74 ± 0.15c 53.17
D371.5 8.66 ± 0.04a 7.84 ± 0.04b 5.62 ± 0.51c 5.32 ± 0.05c 61.43
D372.20 9.10 ± 0.06a 7.85 ± 0.03b 5.99 ± 0.03c 4.56 ± 0.33d 50.09
D373.37 8.53 ± 0.05a 7.57 ± 0.09b 6.27 ± 0.2c 6.23 ± 0.02c 72.99
I379.8 8.95 ± 0.04a 8.25 ± 0.03b 7.02 ± 0.04c 6.88 ± 0.02d 76.88
L. coryniformis I306.12 8.71 ± 0.093a 8.56 ± 0.12a 6.80 ± 0.25b 6.71 ± 0.03b 77.04
H307.1 8.80 ± 0.09a 8.09 ± 0.13b 6.13 ± 0.06c 6.18 ± 0.04c 70.20
C305.1 8.25 ± 0.01 0 0 0 0
H307.6 9.66 ± 0.24a 8.54 ± 0.04b 7.80 ± 0.05c 7.09 ± 0.10d 73.44
H376.2 8.55 ± 0.05 0 0 0 0
H376.5 8.35 ± 0.01a 7.54 ± 0.14b 5.55 ± 0.41c 5.49 ± 0.15c 65.82
H377.3 8.76 ± 0.06a 8.21 ± 0.04b 6.98 ± 0.04c 6.96 ± 0.01c 79.49
L. rhamnosus GG 8.7 ± 0.021a 8.1 ± 0.39b 6.9 ± 0.04c 6.1 ± 0.04d 69.91
Values represent mean log (CFU/ml) ± standard deviation. Distinct letters indicate significance at p value < 0.05 among log (CFU/ml) values for the different tested conditions, within
each strain.
Survival capacity is expressed as the percentage of 1– [(log CFU/mlt0 – log CFU/mlSPJ3h)/log CFU/mlt0 ].
only bacterial source, or on the standard E. coli OP50 diet. The
results are reported in Figure S2. Among the tested strains, the
L. pentosusD303.36 diet induced a relevant increase in C. elegans
longevity (Figure S2A), and animals fed L. coryniformis H307.6
showed similar viability with respect to those fed the probiotic
strain LGG (Figure S2B). On the other hand, when compared to
the control OP50 diet, none of the other tested strains determined
significant increase in worm lifespan, with the exception of
L. pentosus D371.5 (Figure S2A) and L. coryniformis H376.2
(Figure S2B), which led to significant lifespan reduction when
used as the sole dietary source of bacteria. The L. coryniformis
strain I306.12 induced an embryonic lethal phenotype, since
embryos failed to develop into larvae (data not shown).
Therefore, the two L. pentosus D303.36 and L. coryniformis
H307.6 strains were considered as the most promising candidates
in terms of health-promoting features, and were selected for
further analysis. Figure 2A shows that nematodemedian survival
was recorded at days 18 and 15 when worms were fed L. pentosus
D303.36 and L. coryniformis H307.6, respectively, as compared
to 9.5 days in the case of OP50-fed worms. The above described
effects on the longevity phenotype were not observed when
worms were fed heat-killed bacteria, as shown in Figure 2B.
Microscopic observation allowed to evaluate other
physiological effects promoted by the Lactobacillus strains
in C. elegans: animals fed L. pentosus D303.36 or L. coryniformis
H307.6 displayed reduced size with respect to OP50-fed animals
along all developmental stages, similarly to the effect of feeding
the probiotic strain LGG (Figure 2C). Moreover, C. elegans
progeny production was significantly reduced when nematodes
were fed L. pentosus D303.36 or L. coryniformis H307.6, with
about 60% reduction of progeny number in both cases as
compared to OP50-fed animals. A similar reduction was also
observed in the case of LGG-fed animals, although to a lesser
extent (Figure 2D).
Subsequently, aging biomarkers were analyzed in order to
evaluate the prolonged lifespan of C. elegans supplemented
with the different isolates at 13 days of adulthood. The
neuromuscular functionality of nematodes was investigated
by measuring contractions of the pharynx to assess whether
L. pentosus D303.36 and L. coryniformis H307.6 strains could
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TABLE 3 | Antibiotic resistance of L. pentosus and L. coryniformis strains.
Antibiotica
Bacterial
species
Strain ID Ampicillin
(2 mg/l)
Tetracycline
(32 mg/l)
Chloramphenicol
(8 mg/l)
Erythromycin
(1 mg/l)
L. pentosus C305.5 S S S S
D301.4 R (20) S S S
D302.23 R (20) S S S
D302.29 R (2) S S S
G306.1 R (8) S S S
G306.2 R (4) S S S
G308.65 R (16) S S S
H3010.5 R (4) S S S
I306.2 R (8) S S S
H308.2 R (12) S S S
I308.32 R (8) S S S
G377.8 R (4) S S S
G378.30 R (8) S S S
D303.36 R (16) S S R (2.5)
H3010.1 R (4) S S R (1.25)
D371.5 R (4) S S S
D372.20 R (8) S S S
D373.37 R (8) S S S
I379.8 R (4) S S R (2.5)
Ampicillin
(10 mg/l)
Tetracycline
(30 mg/l)
Chloramphenicol
(30 mg/l)
Erythromycin
(15 mg/l)
L. coryniformis I306.12 S S S S
H307.1 S S S S
C305.1 S S S S
H307.6 S S S S
H376.2 S S S S
H376.5 S S S S
H377.3 S S S S
aEach antibiotic was used at the microbiological breakpoint indicated in parenthesis,
according to the bacterial species.
LAB strains resulting sensitive or resistant to antibiotic are referred as S or R, respectively.
MIC values (expressed as mg/l) for resistant strains are indicated in parenthesis.
impact on C. elegans swallowing capacity. Pharyngeal pumping
rates increased when each of the two strains were administered
to nematodes, with respect to the OP50 control (Figure 3A).
In parallel, analysis of the locomotion behavior was performed
to determine possible modifications of C. elegans mobility.
Similarly to LGG-fed worms, body bending was increased when
feeding L. coryniformis H307.6 as compared to OP50. On
the other hand, the L. pentosus D303.36-based diet did not
show any effect (Figure 3B). Evaluation of intestinal lipofuscin
accumulation was performed as an additional aging biomarker.
Fluorescence microscope analysis revealed a reduced fluorescent
signal, diffused throughout the body of nematodes fed L. pentosus
D303.36 or L. coryniformis H307.6. Similar results were obtained
when feeding the probiotic control strain LGG. By contrast,
nematodes fed OP50 showed intense fluorescence accumulating
in large granules along the intestine, typical of aged animals
(Figure 3C).
To evaluate their colonization capacity, bacteria were
recovered from C. elegans gut and quantified by measuring
TABLE 4 | Antimicrobial activity of L. pentosus and L. coryniformis strains against
indicator pathogens.
Pathogen strain
Bacterial
species
Strain ID S. enterica serovar
Typhimurium LT2
L. monocytogenes
OH
ETEC
K88
L. pentosus C305.5 − + +
D301.4 ++ + ++
D302.23 ++ ++ ++
D302.29 ++ + +
G306.1 ++ + +
G306.2 ++ ++ ++
G308.65 ++ + +
H3010.5 + ++ ++
I306.2 ++ ++ ++
H308.2 ++ + ++
I308.32 ++ ++ +
G377.8 + ++ ++
G378.30 + ++ ++
D303.36 ++ + +
H3010.1 ++ ++ ++
D371.5 + ++ ++
D372.20 + ++ ++
D373.37 + + ++
I379.8 + ++ ++
L. coryniformis I306.12 + + +
H307.1 ++ + ++
C305.1 + + +
H307.6 + + +
H376.2 + + +
H376.5 + + +
H377.3 ++ + ++
Inhibitory activities refer to the measured inhibition halo diameter and are indicated as: –
(diameter <1mm);
+ (1mm < diameter < median value); ++ (diameter > median value).
CFUs at 10-days adulthood stage. Both L. pentosus D303.36 and
L. coryniformis H307.6 strains showed a colonization capacity
almost identical to that of the probiotic control strain LGG (data
not shown).
Probiotic strains were reported to protect C. elegans against
infection mediated by several pathogens (Park et al., 2014;
Neuhaus et al., 2017). Since both L. pentosus D303.36 and
L. coryniformis H307.6 strains displayed antimicrobial activity
against the three tested pathogens (Table 4), these two LAB
strains were evaluated also for their protective potential in
C. elegans against pathogen infection mediated death. S. enterica
serovar Thyphimurium LT2 or L. monocytogenes OH were
chosen for the assay as they represent important foodborne
pathogens. The results in Figure 4 demonstrate that C. elegans
displayed reduced survival on NGM medium when fed
S. enterica Thyphimurium LT2 alone, as compared to nematodes
supplemented with co-cultures of the same pathogen with
L. pentosus D303.36 or L. coryniformis H307.6. In the case of
L. monocytogenes OH, on the other hand, neither one of the
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FIGURE 2 | Effect of the L. pentosus D303.36 and L. coryniformis H307.6 strains on C. elegans lifespan, body length, and fertility. (A) Kaplan–Mèier survival plots of
N2 fed L. p. D303.36 and L. c. H307.6 strains, starting from embryo hatching; n = 60 for each single experiment. Lifespans of OP50- and LGG-fed animals are
reported as controls. (B) Survival of C. elegans fed heat killed bacterial strains. Statistical analysis was evaluated by one-way ANOVA with the Bonferroni post-test;
asterisks indicate significant differences (*p < 0.05; **p < 0.01; ***p < 0.001). (C) Effect of bacteria on larval development. Worm length was measured from head to
tail at the indicated time points. Statistical analysis was performed by one-way ANOVA with the Bonferroni post-test; different letters indicate significant differences
(p < 0.05). (D) Embryo production per worm in animals fed different bacterial strains. Bars represent the mean of three independent experiments (**p < 0.01;
***p < 0.001).
co-cultures was able to abrogate premature death of the animals
(data not shown).
Reduction of Pathogen Adhesion to Human
Intestinal Epithelial Cells by L. pentosus
D303.36 and L. coryniformis H307.6 Strains
Several pathogens, including S. enterica serovar Typhimurium,
L. monocytogenes and ETEC, are able to adhere to the
brush border of intestinal cells, damaging the structure of
tight or adherens junctions (Boyle and Finlay, 2003; Köhler
et al., 2007). Increasing evidence highlights the capacity of
lactobacilli to inhibit pathogen adhesion to the intestinal mucosa
and counteract the associated inflammatory processes, thus
preventing intestinal disease in both humans and animals (Zhou
et al., 2010; Asahara et al., 2011). The two L. pentosus D303.36
and L. coryniformis H307.6 strains were therefore analyzed for
their capacity to reduce pathogen adhesion to Caco-2 cells,
which represent a valuable in vitro model of human intestinal
epithelium. Both strains, which were previously tested for their
adhesion ability to Caco-2 cells (data not shown), were co-
cultured with intestinal cells in combination with S. enterica
serovar Typhimurium LT2 or L. monocytogenes OH.
Treatment of intestinal cells with L. pentosus D303.36 or
L. coryniformis H307.6 reduced adhesion of S. enterica serovar
TyphimuriumLT2 by about 0.5 log CFU/ml (Figure 5). Statistical
analysis performed by ANOVA revealed p-values < 0.05,
indicating that, although to a mild extent, both strains were able
to significantly counteract pathogen attachment to the cells. On
the other hand, no protective effect of L. pentosus D303.36 or
L. coryniformis H307.6 against L. monocytogenes OH could be
observed (data not shown).
DISCUSSION
Table olives are increasingly recognized as a potential natural
source of probiotic bacteria that could be exploited to
obtain a health-promoting functional product (Bonatsou
et al., 2017). Different olive cultivars are characterized by
specific autochtonous fermenting microbiota (Heperkan,
2013), representing a valuable reservoir of novel strains of
environmental origin. In particular, Nocellara del Belice is
an important Italian olive cultivar, awarded the official PDO
designation (Protected Designation of Origin, EC Regulation
No 134/1998), whose microbial composition is dominated by
several LAB species of technological and health-related interest
(Aponte et al., 2010, 2012; Zinno et al., 2017). In the present
work, a combination of in vitro and in vivo approaches was
used to select novel potentially probiotic Lactobacillus strains
deriving from a LAB collection of isolates from Nocellara del
Belice table olives fermented with Spanish or Castelvetrano
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FIGURE 3 | Analysis of aging markers in C. elegans fed the L. pentosus D303.36 and L. coryniformis H307.6 strains. (A) Pumping rate of 13-days-old worms,
measured for 30 s and determined from the mean of 10 worms for each bacterial strain. Worms fed OP50 or LGG were used as controls. (B) Body bend frequency,
measured for 30 s, of C. elegans fed different Lactobacillus strains or OP50. Statistical analysis was performed by one-way ANOVA with the Bonferroni post-test;
asterisks indicate significant differences (*p < 0.05, **p < 0.01). (C) Autofluorescence of lipofuscin granules in C. elegans fed different bacterial strains on day 13. Ten
worms were used for each measurement. Scale bar = 100µm.
methods, that was previously established in our laboratory
(Zinno et al., 2017). Characterization of LAB isolates at the
species level identified Leuconostoc mesenteroides, L. pentosus,
and L. coryniformis as the predominant species, along with
L. oligofermentans, E. gallinarum, and E. casseliflavus as
minor components. Among these isolates, L. pentosus and
L. coryniformis were chosen as potential probiotic candidates
for further analysis since increasing experimental evidence
reports on health-promoting features displayed by several
strains belonging to these species (Olivares et al., 2006; Abriouel
et al., 2017; Bendali et al., 2017). Probiotic traits are known
to be strain-specific (Saulnier et al., 2009; Amund, 2016), it is
therefore important to consider that all selected L. pentosus and
L. coryniformis isolates analyzed in this work displayed distinct
fingerprinting profiles, therefore representing unique and novel
strains.
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FIGURE 4 | Rescuing potential of L. pentosus D303.36 and L. coryniformis
H307.6 against Salmonella enterica infection. Kaplan–Mèier Survival plot of
C. elegans fed L. pentosus D303.36 or L. coryniformis H307.6 in a 1:1
co-colture with S. enterica serovar Thyphimurium LT2. Worms fed Salmonella
alone were taken as control (**p < 0.01; ***p < 0.001).
Resistance to the harsh conditions of the upper GI tract
is a key pre-requisite for efficient colonization by a probiotic
strain (Dicks and Botes, 2010). As a first predictive phenotypic
trait, tolerance to gastrointestinal conditions was assessed by
evaluating the survival capacity of each strain in comparison with
the well-characterized, commercial probiotic strain L. rhamnosus
GG. Overall, the majority of the investigated strains showed
50–80% survival capacity to gastric and pancreatic juice
treatments, with strain-dependent variability. Notably, 11 of the
26 Lactobacillus strains assayed in this study displayed survival
rates equal or higher than that of the well characterized probiotic
control strain LGG (70%) at the end of simulated digestion
treatments, thus pointing at the diet, and to fermented foods
in particular, as a relevant source of live microorganisms that
can reach the host gut microbiota in a metabolically active state,
where they can transiently colonize and interact with resident
gut bacteria. An important trait to be verified for safety purposes
concerns antibiotic resistance profiling (Imperial and Ibana,
2016). To this aim, all the L. coryniformis and L. pentosus strains
were also analyzed for resistance to ampicillin, tetracycline,
chloramphenicol or erythromycin, as representatives of distinct
pharmacological classes of antimicrobials commonly used
in human and veterinary medicine (Aminov, 2017). While
the majority of the tested strains were susceptible to these
antibiotics, all but one of the L. pentosus isolates showed
phenotypic resistance to ampicillin, with a few of them diplaying
erythromycin resistance as well. These strains will be subjected
to further analysis to identify the corresponding antibiotic-
resistance determinants and their genomic contexts, so that
possible horizontal transmission can be ascertained.
Probiotics are known to be effective in preventing or
counteracting foodborne infections by reducing the growth
of enteric pathogens through different mechanisms, involving
competitive exclusion or the production of inhibitory molecules
(Karami et al., 2017; Mathipa and Thantsha, 2017). We therefore
tested the antimicrobial activity exerted by the L. pentosus and
L. coryniformis strains against three common pathogens, namely
FIGURE 5 | Reduction of Salmonella enterica adhesion to Caco-2 cells by
L. pentosus D303.36 and L. coryniformis H307.6. Cell counts of viable
S. enterica serovar Thyphimurium LT2 adhering on differentiated Caco-2 cells
treated with: S. enterica alone (control, white column); S. enterica in
combination with L. pentosus D303.36 (black column) or L. coryniformis
H307.6 (gray column). Columns represent the mean ± SD of four independent
experiments. Data are reported as log of bacterial CFU recovered after plating.
Statistical analysis was performed by one-way ANOVA, followed by post-hoc
Tukey honestly significant difference (HSD) test. Asterisks indicate significant
differences (*p < 0.05 vs. control).
S. enterica serovar Typhimurium, L. monocytogenes and ETEC.
The great majority of the Lactobacillus isolates screened in this
work resulted to be active against all three pathogens in vitro,
although with variable, strain-specific efficacy.
At the end of this in vitro screening, 3 L. coryniformis
strains appeared to be good candidate probiotics on the basis
of their positive performance under simulated gastro-intestinal
digestion, antibiotic susceptibility, and antimicrobial activity.
However, only one of these strains was also selected by parallel
screening for health-promoting traits in the in vivo nematode
model C. elegans. This simplified model organism lives on
bacteria as the only food source, but a substantial number of
bacterial cells escape the grinding capacity of the worm larynx
and can proceed to colonize the nematode gut (Nakagawa et al.,
2016). The L. coryniformis H307.6 strain was able to significantly
increase C. elegans lifespan as compared to the OP50 control
strain, overlapping the effect exerted by the well characterized
probiotic strain LGG, while positively impacting also on other
well-established aging biomarkers such as pharyngeal pumping
rate, body size, brood size, and lipofuscin (Lee et al., 2015).
These results further confirm the ability of specific LAB strains
to extend nematode lifespan as reported in previous studies
(Ikeda et al., 2007; Komura et al., 2013; Nakagawa et al.,
2016). Moreover, the L. coryniformis H307.6 displayed health-
promoting activities also in host defense against S. enterica
serovar Typhimurium, both in vitro (inhibiting pathogen growth
as well as competing with pathogen for intestinal cell adhesion),
and in vivo (increasing survival of infected worms). It is worth
mentioning in this respect that host-pathogen interactions have
been investigated in C. elegans for a number of pathogens of
human and animal origin (Clark and Hodgkin, 2014), including
S. enterica and L. monocytogenes which are able to colonize
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TABLE 5 | Summary table listing the main features displayed by the candidate probiotic strains identified in this study.
Species/strain ID C. elegans GI tract survival (%) Antimicrobial activity Antibiotic resistance
Longevity Colonization In vitro Caco-2 C. elegans Growth on antibiotic* MIC (mg/ml)
L. coryniformis H307.1 − ND 70.20 +++ ND ND S NA
L. coryniformis H377.3 − ND 79.49 +++ ND ND S NA
L. coryniformis H307.6 + + 73.44 + +(Salmonella) +(Salmonella) S NA
L. pentosus D303.36 ++ + 51.65 ++ +(Salmonella) +(Salmonella) R(Amp, Ery) Amp = 16Ery = 2.5
*growth in the presence of breakpoint concentration of antibiotics; R, Resistant to the specified antibiotics; S, Susceptible to all tested antibiotics.
MIC, Minimum Inhibitory Concentration, determined only for strains which survived breakpoint concentrations for the specified antibiotics.
ND, Not Determined; NA, Not Applicable.
the worm gut and infect the nematode (Aballay et al., 2000;
Thomsen et al., 2006). A second isolate, namely L. pentosus
D303.36, was positively selected in C. elegans as a lifespan
extending, health-promoting strain. This strain, however, did
not display good performance with respect to tolerance to
GI tract conditions, and was also resistant to ampicillin and
erythromycin. Therefore, further molecular characterization
is necessary to exclude potential horizontal transmission of
antibiotic resistance before it can be considered a promising
probiotic candidate.
On the other hand, L. coryniformis strains H307.1 and
H377.3, that were selected as very good performers in the
initial in vitro testing screens, were both antibiotic susceptible,
as well as capable of inhibiting pathogen growth in the agar
double-layer diffusion assay. However, neither one of these
two strains could positively impact on C. elegans longevity.
Table 5 summarizes the main features displayed by the candidate
probiotic strains identified in this study. In light of the recent
findings indicating that probiotic capacity of mixed foodborne
microbial consortia might be more effective than single strain
supplementation (Foligné et al., 2016; Roselli et al., 2017), testing
these strains as members of a multistrain probiotic complex
could open new avenues for their applications in vegetable food
fermentations.
CONCLUSIONS
Extensive in vitro and in vivo characterization of 26 Lactobacillus
strains previously isolated from fermented Nocellara del Belice
table olives, led to the identification of various potential candidate
probiotics. Of these, three L. coryniformis strains displayed good
probiotic features in vitro, although only one of them could
also exert prolongevity and protective effects in the simplified
model organism C. elegans. The GRAS status of Lactobacilli
allows to consider their application as starters of fermentation
with probiotic added value. However, further validation in in vivo
trials with more complex animal or human systems should be
performed to gain deeper understanding of their potential health
promoting features for human health.
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